BridgeBio, DKSH Partner to Combat Rare Heart Disease

DKSH has teamed up with BridgeBio to bring a new treatment for a rare heart disease, ATTR-CM, to Australia, Singapore, South Korea, and Taiwan. This partnership aims to help get the treatment approved and accessible for patients in these areas, combining BridgeBio's biotech smarts with DKSH's healthcare distribution skills. What does it mean for you? If you or someone you know is in one of these countries and affected by this rare heart condition, there might soon be a new treatment option available, pending approval.